Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ)
- Previous Close
11.77 - Open
9.53 - Bid 11.97 x --
- Ask 11.98 x --
- Day's Range
11.89 - 13.00 - 52 Week Range
4.30 - 17.98 - Volume
107,156,437 - Avg. Volume
53,977,299 - Market Cap (intraday)
11.001B - Beta (5Y Monthly) 0.21
- PE Ratio (TTM)
-- - EPS (TTM)
-0.47 - Earnings Date --
- Forward Dividend & Yield 0.01 (0.04%)
- Ex-Dividend Date Jun 27, 2023
- 1y Target Est
--
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally. It offers crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadri heparin calcium API, nandroparin calcium injection, and dalteparin sodium API and injection. The company was founded in 2000 and is based in Shijiazhuang, China.
www.hbcsbio.comRelated News
Performance Overview: 300255.SZ
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300255.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300255.SZ
Valuation Measures
Market Cap
10.82B
Enterprise Value
12.96B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.93
Price/Book (mrq)
4.06
Enterprise Value/Revenue
7.71
Enterprise Value/EBITDA
-34.91
Financial Highlights
Profitability and Income Statement
Profit Margin
-26.05%
Return on Assets (ttm)
-3.05%
Return on Equity (ttm)
-15.49%
Revenue (ttm)
1.68B
Net Income Avi to Common (ttm)
-438.11M
Diluted EPS (ttm)
-0.47
Balance Sheet and Cash Flow
Total Cash (mrq)
311.08M
Total Debt/Equity (mrq)
92.55%
Levered Free Cash Flow (ttm)
-139.71M
Research Analysis: 300255.SZ
Company Insights: 300255.SZ
300255.SZ does not have Company Insights